iCeutica’s SoluMatrix technology is solving bioavailability and delivery challenges for a range of developmental and marketed products.

A number of products developed using the SoluMatrix technology platform are currently in clinical trials in the US.

We are currently working with a range of small and large pharmaceutical and biotechnology companies in the United States and Europe. We have established relationships with GMP manufacturing facilities in the US which are capable of utilizing the SoluMatrix technology to produce a range of finished dosage forms.

For a view of our current internal and partnered pipeline click here.